Farther Finance Advisors LLC Buys 663 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Farther Finance Advisors LLC grew its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 11.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,433 shares of the financial services provider’s stock after buying an additional 663 shares during the period. Farther Finance Advisors LLC’s holdings in iShares Biotechnology ETF were worth $850,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in IBB. Aptus Capital Advisors LLC boosted its holdings in iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after buying an additional 114 shares during the last quarter. Oppenheimer & Co. Inc. boosted its holdings in iShares Biotechnology ETF by 0.7% during the third quarter. Oppenheimer & Co. Inc. now owns 35,663 shares of the financial services provider’s stock worth $5,193,000 after buying an additional 237 shares during the last quarter. Huntington National Bank boosted its holdings in iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after buying an additional 160 shares during the last quarter. Sargent Investment Group LLC bought a new position in iShares Biotechnology ETF during the third quarter worth about $211,000. Finally, OneDigital Investment Advisors LLC boosted its holdings in iShares Biotechnology ETF by 32.7% during the third quarter. OneDigital Investment Advisors LLC now owns 10,805 shares of the financial services provider’s stock worth $1,573,000 after buying an additional 2,661 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.8 %

Shares of IBB opened at $134.19 on Friday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The stock has a market cap of $6.34 billion, a P/E ratio of 24.52 and a beta of 0.84. The stock’s 50-day moving average price is $136.25 and its two-hundred day moving average price is $139.96.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.